A 66-year-old man had a progressive increase in the pacing threshold over a one-year period, resulting from chronic myocarditis. Following steroid therapy, the pacing threshold decreased and became stabilized, and was accompanied by a decrease in the serum creatine kinase, cardiac myosin light chains and pro-collagen III peptide values, but cardiac function did not improve. Endocardial biopsy showed that there was no progression in the fibrosis. The pacing failure improved, but the cardiac function did not. It was believed that the steroid therapy suppressed the progression of the inflammation and fibrosis caused by the chronic myocarditis. 
Introduction
Acute myocarditis causes complex arrhythmias and heart failure. The inflammation observed in the myocardium occasionally continues for a prolonged period (chronic myocarditis), resulting in progression of fibrosis. For prolonged periods of inflammation, adrenocorticosteroid therapy (steroid therapy) is usually given, but its effect remains controversial (1) (2) (3) (4) (5) . In the present case, the efficacy of the steroid therapy was demonstrated in a case with chronic myocarditis using myocardial biopsy, serum pro-collagen III peptide (P-III -P) values and other clinical findings, and therefore we report this case here.
Case Report
A 66-year-old man was admitted to our institution in November 2000, for sick sinus syndrome with slight congestive heart failure. At the initial interview, the patient reported that he had developed common cold-like symptoms which had begun in April 2000, and that he had noticed edema of his legs and exertional dyspnea since May 2000, which lead to the suspicion of post-myocarditis heart failure. When he was first admitted to our institution, slightly elevated levels of muscle enzymes were detected by blood tests. On electrocardiogram, his heart rate was 46 beats/min, and sinus arrest and ventricular escape beats were observed. Thus, the patient was diagnosed as having type II sick sinus syndrome classified according to the Rubenstein system. The echocardiogram, coronary angiogram and left ventriculogram revealed diffuse left ventricular disease (left ventricular ejection fraction; LVEF 30.1%), and consequently the origin was diagnosed by endocardial biopsy ( Fig. 1A ; infiltration of inflammatory cells) as myocarditis. Electrophysiological study (EPS) revealed right atrial standstill, and thus his sick sinus syndrome was diagnosed as originating from myocarditis.
A permanent cardiac pacemaker (VVI pacing, pacing threshold 0.35 V, and pulse width 0.40 ms) implantation improved the patient's heart rhythm and heart failure. However, the pacing threshold gradually increased month by month. In July 2001, the threshold had reached 3.80 V at a pulse width of 0.40 ms. No problems with either the pacemaker or pacing lead were detected, and consequently an endocardial biopsy of the right ventricle was performed once again, revealing progression of the chronic myocarditis ( For editorial comment, see p 167.
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of inflammatory cells and an increase in the intercellular fibrosis). In order to place an additional pacing lead, pacing thresholds from various locations (around the apex, inferior wall, outflow tract, etc.) were measured (many of them resulting in a threshold >5.00 V at a pulse width of 0.40 ms).
As a result, a new lead was placed in the right ventricular apex with a pacing threshold of 0.85 V at a pulse width of 0.40 ms. The previous pacing lead was extracted. In October 2001, the threshold again showed an increase (1.35 V at a pulse width of 0.40 ms). This was believed to be related to the progression of the myocarditis, and therefore the patient was re-admitted to our institution. The results of the blood examination on admission are shown in Table 1 . There was a slight increase in the creatine kinase (CK; 290 IU/l, 10.3% for the CK-MB), immune globulins and erythrocyte sedimentation rate. At that time, the P-III-P was also measured, but it was found to be 0.8 U/ml, which is within normal limits. The chest X-ray and electrocardiogram are shown in Fig. 2 . A 60% cardiothoracic ratio (CTR) and full ventricular pacing (VVI) were observed. Administration of prednisolone (60 mg/day) was initiated, and the amount was gradually decreased by 10 mg every 2 weeks. Following prednisolone administration, the serum CK and P-III-P decreased. Further, the pacing threshold also decreased 3 weeks after beginning prednisolone administration (Fig. 3) . The biopsy findings 5 weeks after beginning the administration of prednisolone (Fig. 1C) revealed slight infiltration of mononuclear cells, but it was diagnosed as a greater improvement than that before the administration.
A comparison was made between the data obtained before the steroid therapy and that obtained 5 weeks after the therapy had begun. A decrease in the CTR from 60 to 57%, serum CK from 290 to 50 IU/l, serum P-III-P from 0.8 to 0.4 U/ml, serum cardiac myosin light chains from 8.0 to 4.5 ng/ml, pulmonary capillary wedge pressure from 19 to 18 mmHg, cardiac index from 3.28 to 3.19 l/min/m 2 and pacing threshold from 1.35 V (pulse width 0.40 ms) to 1.05 V (0.40 ms), and an increase in the LVEF from 30.1 to 31.5% (measured by leftventriculography) were observed.
The steroid therapy has been performed at the outpatient clinic, using methylprednisolone at a dose of 4 mg/day. His pacing threshold was 1.05 V at a pulse width of 0.40 ms in April of 2003, without any increase after discharge.
Discussion
"Pacing failure" has been described to be caused by such occurrences as dislodgement of the implanted lead, fracture of the lead, administration of class I anti-arrhythmic agents, inflammatory processes around the implanted lead and myocardial infarction. It is known that pacing failure can occur due to prolonged periods of myocarditis (chronic myocarditis) that progress over the long term. Arima et al (6) reported a case in whom atrio-ventricular block occurred 7 years after the occurrence of acute myocarditis. They concluded that it was due to chronic myocarditis. In chronic myocarditis, the disturbance of the myocytes is considered to be caused by the cellular immunity associated with a viral infection (7, 8) . This disturbance causes arrhythmias and heart failure. Steroid therapy and immunosuppressive therapy have been introduced, but their efficacy remains controversial (1) (2) (3) (4) (5) .
In the present case, the pacing threshold continued to increase over one year. From the endocardial biopsy findings, the cause was considered to be chronic myocarditis. No other clinical findings which might be suspected as the origin of the pacing failure could be obtained. The pacing threshold normally increases for 1-2 weeks after pacemaker implantation due to the occurrence of fibrosis and myocardial necrosis occurring around the electrode, and stabilizes thereafter. Steroid-eluting electrodes are thought to prevent the transient increase in pacing thresholds after implantation compared with non-steroid-eluting electrodes (9) . Thus steroid-eluting electrodes were used for both pacemaker implantations in the present patient. However, his steroid-eluting electrodes were thought to exert no sufficient effects because of the presence of persistent widespread inflammation and fibrosis in the myocardium due to the chronic myocarditis, instead of the usual transient fibrosis and/or myocardial necrosis localized around the electrode.
After starting the steroid therapy, there was an improvement and stabilization of the pacing threshold, decrease in the serum CK, P-III-P and cardiac myosin light chains, and the progression of the inflammation of the myocardium was suppressed. However, the cardiac function did not improve. The serum P-III-P value has never been used for determining the effect of the treatment of myocarditis. An increase in the P-III-P directly reflects the multiplication of collagen, thus the serum P-III-P value implies a biochemical marker for fibrosis of internal organs. To date, the serum P-III-P value has been used as a marker for diagnosing and determining the fibrosis in liver disease (10) . That value is known to increase in hypertensive ventricular hypertrophy, dilated cardiomyopathy and acute myocardial infarction (up to 4 months) (11) (12) (13) (14) . In heart disease, the P-III-P also is considered to imply fibrosis of the heart. In the present case, the serum P-III-P value decreased following the steroid therapy, along with a decrease in the serum CK and cardiac myosin light chains, and according to the endocardial biopsy findings, the progression of the inflammation of the myocardium was suppressed. These findings suggested that the progression of the fibrosis in the myocardium was suppressed. Thus, the steroid therapy was considered to be able to suppress the progression of fibrosis in chronic myocarditis.
Conclusion
This case was thought to be a very useful because the effect of the steroid therapy on the chronic myocarditis was confirmed based on the histopathological findings of the myocardium and time-sequence measurements of the pacing threshold. 
